SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-194777
Filing Date
2014-05-12
Accepted
2014-05-12 16:03:51
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d706409d10q.htm 10-Q 160224
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d706409dex311.htm EX-31.1 6084
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d706409dex312.htm EX-31.2 6087
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d706409dex321.htm EX-32.1 2808
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d706409dex322.htm EX-32.2 2820
  Complete submission text file 0001193125-14-194777.txt   1578915

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20140331.xml EX-101.INS 113456
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20140331.xsd EX-101.SCH 24183
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20140331_cal.xml EX-101.CAL 20643
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20140331_def.xml EX-101.DEF 84525
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20140331_lab.xml EX-101.LAB 181865
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20140331_pre.xml EX-101.PRE 122079
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 14833408
SIC: 8731 Services-Commercial Physical & Biological Research